Thursday, 29 January 2015

9th Pharma Festival at Nagpur

Smt. Kishoritai Bhoyar College of Pharmacy and APTI are organizing 9th Pharma Festival, National level Dance Competition "Kshitij: 2014-15".


The details are as follows:

Theme:              Kshitij: Endless limit to success

Dates:               2nd February 2015.

Organized by:   APTI and Smt. Kishoritai Bhoyar College of Pharmacy . 
 
Location:           Nagpur, India.

INNOPHARM 1 - 1st International Conference on Novel Frontiers in Pharmaceutical & Health Sciences

Innovare Academics Sciences is organizing 1st International Conference on Novel Frontiers in Pharmaceutical & Health Sciences (INNOPHARM 1).
 
INNOPHARM 1 will feature leading international speakers and bring together researchers, academicians, Pharma industrialist, healthcare professionals, healthcare technology providers, Pharmacists and experts of various pharmaceutical fields from all over the world to discuss and share novel frontiers in pharmaceutical and health sciences.
 
The details are as follows:

Theme:   International Conference on Novel Frontiers in Pharmaceutical & Health Sciences.

Dates:               10th -11th October 2015.

Organized by:   Innovare Academics Sciences . 
 
Location:           Minal Campus, Ayodhya Bypass Road, Bhopal 462041 MP, India
 
Details available at:
 

Tuesday, 27 January 2015

Pharma academic research - Indian patent applications published on 23rd January 2015

Dear All,
Every week of thousands of patent applications are published in India. The patent applications filed by the academic research institutes in India go un-noticed.
 
We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes.
 
For details of these patents, please write back to us at pharmaliterati@gmail.com
 
Indian patent applications published on 23rd January 2015

Invention
Application No
Inventors
Institute
Compositions and methods for the treatment of cancer
3242/CHE/2013 A
Rajesh
Not known
{Mettupalayam, Tamil Nadu.}
 

Tuesday, 20 January 2015

Dr. Habil Khorakiwala's interview

Habil Khorakiwala, chairman,Wockhardt Group is the new Chancellor of Jamia Hamdard University, New Delhi. He spoke about his vision for the University, the gaps in the Indian higher education sector and the importance of hard work in a conversation with Prachi Rege of Zee News.
 
He highlighted that his focus would be to challenge the faculty to aim for excellence. He further stated that as a Chancellor, it will be his responsibility to give them a reality check of what they are doing and how relevant it is to things happening around them.
 
 

50 posts for Pharma Literati

Dear All,
Thanks a lot for your encouraging support that we have got 50 posts landmark crossed in a span of around 3 months. It is essential to mention that the bloggers are putting their all intellectual efforts to make this blog a success.
 
We would be more than pleased see the contribution from the authors as well. Also, request all the students, faculties and industry professionals to share the blog with their colleagues, friends and students.
 
Team Pharma Literati

Government to supply 500 low-cost Jan Aushadhi Drugs in local stores from July

The economic times reports that,  you may be able to buy nearly 500 low-cost drugs supplied by the government at your neighbourhood pharmacy from July under Jan Aushadhi brand if a plan proposed by an expert panel is implemented.
 
The drugs are likely to cost 50-95 per cent less than their private branded counterparts, members of the expert committee told ET, adding that the medicines selected under the scheme span six therapeutic categories including cardiovascular, diabetes, respiratory and antibiotics.

Under this proposal, the government plans to start procuring from private players to resuscitate the fledgling Jan Aushadhi scheme which operates through a chain of brick-and-mortar stores and is completely dependent on the handful of public sector units for drug supply that makes it vulnerable to frequent stock-outs.  
 
A limited portfolio of medicines coupled with chronic stock-outs has seriously eroded the credibility of these stores as customers desire a one-stop shop for all prescribed drugs, the consultancy found. A study found the mean availability of drugs at these stores stood at only 33 per cent. The department of pharmaceuticals, the nodal ministry for implementation of the scheme, has reached out to the doctors urging them to prescribe generic drugs. It recently held meetings with the Indian Medical Association, a grouping of over two lakh doctors spread across the country and Medical Council of India, the statutory body which maintains a register of all qualified and practising doctors in the country, to boost generic prescriptions.

Read more at:

Piramal Acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.

The Telegraph reports that Piramal announced that it has invested USD 30.65 million towards acquiring Coldstream Laboratories Inc. (‘Coldstream’), through its wholly owned subsidiary in the USA in an all cash transaction.
 
Coldstream is a Contract Development and Manufacturing Organisation (CDMO) focused on the development and manufacturing of sterile injectable products. Coldstream was founded in 2007 and is majority owned by University of Kentucky Research Foundation (an affiliate of the University of Kentucky). Coldstream is a specialty pharmaceutical contract manufacturer with an emphasis on clinical trial to commercial-scale manufacturing of sterile liquid and lyophilized parenterals and injectables. Coldstream has developed differentiated expertise to formulate and manufacture high potency and cytotoxic compounds including Antibody Drug Conjugates (ADCs). The company operates from a FDA approved facility located in Lexington, Kentucky, USA.
  
Commenting on the acquisition Mr. Vivek Sharma, CEO of PEL’s Pharma Solutions business said “Coldstream is a very high quality operation and has been able to build significant customer relationships and track record for sterile products. We see this as a great platform for growth in our Pharma Solutions business. This acquisition allows PEL to move further into the injectable market segment and should have strong synergy with our existing Pharma Solutions business. Our strong capabilities in sterile product development and in ADC product segment will allow us to offer an integrated solution to our customers.” Bill Wedlake, President of PEL’s Pharma Solutions Formulations business added, “We have been impressed by the quality of the people at Coldstream and their success in both attracting high quality business and also their track record in quality. Coldstream’s use of isolator technology is impressive and provides a foundation for expansion of the facility to provide large scale commercial manufacturing including production of highly potent compounds.”
 

Monday, 19 January 2015

Startups in new drug discovery_Bugworks and Vitas Pharma

The high cost of research and drug discovery has not deterred start-ups from entering the arena of drug discovery. As the economics times reports, start-ups like Bugworks, Vitas Pharma have entered the field of drug discovery.
 
Across geographies, big pharmaceutical companies seem to have stepped back from research and development (R&D) for new drug discovery in this field. That is simply because it's more profitable to find new drugs that focus on lifestyle and other diseases where efficacy isn't diminished by use. But a couple of startups in India have recently entered the field of drug discovery. Take for instance Bugworks in Bengaluru, co-founded by Anand Anandkumar, Janaki Venkatraman and Santanu Datta, and Vitas Pharma in Hyderabad, co-founded by Radha Rangarajan and Rajinder Kumar. 
 
Please see the details at:

Pharma Summit - Changing dynamics, the road ahead

Associated Chambers of Commerce and Industry of India (ASSOCHAM) is organizing the Pharma Summit with the theme “Changing Dynamics the Road Ahead”, 18th February, 2015, Hotel Le Meridien, New Delhi in association with Organization of Pharmaceutical Producers of India (OPPI), Indian Drug Manufacturers' Association (IDMA) and Confederation of Indian Pharmaceutical Industry (CIPI) and Indian Pharmaceutical Association (IPA).
The details are as follows:

Theme:              Changing dynamics, the road ahead.

Dates:               18th February 2015.

Organized by:   ASSOCHAM. 

Location:           New Delhi.


Saturday, 17 January 2015

Indian Institute of Packaging says expiry date on each tablet

The news of Indian Institute of Packaging (IIP), an autonomous body under the Ministry of Commerce, taking up the matter of printing expiry dates behind each tablets, may have caused a flutter among the pharmaceutical companies because of the cost factor, there are positive reactions from the general public and print firms reports PrintWeek India.
 
“Printing of expiry dates of each pill will be impossible to carry out and we are not just talking about the cost factor and reading being difficult to decipher, printing it in red, along the length of the strip, preferable on either side, will be a good idea,” said one response.
 
At present, the expiry date is printed in one corner of the strip along with the batch number and date of manufacturing. But when Ahmedabad-based Zudus Cadilla sent in their entry of Inditel tablets for the IndiaStar 2014 event, with each pocket containing tablet printed with details of product name and expiry, IIP’s director, NC Saha saw this as an opportunity to promote the initiative.
 
Saha says, there are two reasons, why the initiative needs to be promoted. “One, once you start taking the tables off, it is difficult to read the expiry date and batch numbers. This will result in increased efficiency of medicines in curing diseases. Two, Zydus has implemented this and has received overwhelming response.”
 
In a study conducted by students of MGM Medical College in Indore, last March, showed that an alarming number of Indore’s elderly people do not check expiry date of medicine before consuming them, almost every elderly member who were surveyed suggested that the expiry dates of medicines should be printed in bigger size number and in different colour. Printing bigger sizes expiry dates is an idea, this however, does not eliminate the problems mentioned above.
 
Either ways, it has vindicated IIP’s stand that the issue of expiry date needs to be tackled.  While implementing this Zydus initiative would inflate the printing cost, Saha says, Zydus has done this as part of their CSR initiative. “The industry has to wake up to these basic problems, and such initiatives can easily be absorbed by their CSR initiative.”
 
IIP, which works closely with the Pharmaceutical Export Promotion Council of India, plans to take this up with the policy makers.
 
Needless to say, print industry sees this as a boost to its business. “Bigger sizes, along the length of the strip or on sides, it all means more print,” said a print company who specialises in pharma print.
 
 

Domestic drug sales cross Rs87,000 crore despite pricing control

Despite significant price control on essential drugs across almost all therapy groups, sales by Indian manufacturers in December 2014 grew 14.4%  reports Mint.
 
India’s drug market grew 11% to touch Rs.87,235.19 crore in the 13 months ended 31 December 2014 powered by local drug makers, data showed.
 
The IMS released data for December 2014 as well as for the 13 months from 1 December 2013 to 31 December 2014.
 
The top 10 drug makers accounted for 40% of sales in the 13-month period. Among the top 10 companies, Cipla Ltd grew 24%. Eighteen of its products are among the country’s 300 top-selling brands.
 
Anti-infection drugs constituted the biggest therapy segment, with a market share of 13.3% in December.
 
As per December’s moving annual turnover (MAT) Abbott Laboratories group maintained its top position in market share with a market share of 6.45%.
 
Among the top 25 companies, MSD Pharmaceuticals Pvt. Ltd, the Indian unit of US drug maker Merck and Co. Inc., gained 2 ranks and moved to 25th position in December.
 
GlaxoSmithKline Pharma Ltd, Glenmark Pharmaceuticals Ltd, USV Ltd, Micro Labs Ltd and Novartis Ltd gained one rank each and moved to 7th, 17th, 18th, 20th and 22nd positions respectively.
 
Indian companies continued to capture the larger share of the market at 73% during December, with a sales growth of 14.4%. Foreign drug makers accounted for about 30% of the market, with 3 of them (Abbott, GSK Pharma and Pfzer Ltd) in the top ten group.
 
Acute or short-term therapies continued to dominate the market accounting for 68.6% of the market with a growth of 11.1% and chronic therapies registered higher growth of 16.5% in December 2014.
Cough preparation was the highest selling therapeutic subgroup in value terms, the IMS December data showed.
 
Anti-diabetic and cardiac therapies recorded 20% and 15% value growth respectively during the last 12 months (MAT December 2014), according to IMS research.
 
 

Pharma academic research - Indian patent applications published on 16th January 2015

Dear All,
Every week of thousands of patent applications are published in India. The patent applications filed by the academic research institutes in India go un-noticed.
 
We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes.
 
For details of these patents, please write back to us at pharmaliterati@gmail.com
 
Indian patent applications published on 16th January 2015

Invention
Application No
Inventors
Institute
Formulation and evaluation of transdermal patch for Sildenafil citrate
2106/DEL/2013 A
1) Prof. S.S. Agrawal
2) Mr. Dheeraj Nagpal
Amity University, Noida, Uttar Pradesh
Formulation of pH sensitive mucoadhesive microspheres of omeprazole
2107/DEL/2013 A
1) Yogesh Singh Rathore
2) Jyoti Rathore
Amity University, Noida, Uttar Pradesh
A topical eye formulation for dry eye disease disorder.
2049/DEL/2013 A
1) Velpandian, Thirumurthy
2) Singh, Smrita
3) Ravi Alok, Kumar
4) Titiyal, Jeewan, Singh
5) Ghosh, Supriyo
6) Sharma, Namrata
7) Halder, Nabanita
8) Vajpayee, Rasik Behari
All India Institute of Medical Sciences (AIIMS)
Department of ocular
pharmacology and pharmacy, New Delhi.
A novel self micro emulsifying composition with P-GP inhibitory activity for enhanced oral bioavailabitity of anticancer agent
2100/DEL/2013 A
1) Talegaonkar, Sushama
2) Negi, Lalit Mohan
3) Mohammad, Tariq
4) Khar, Roop Krishen
5) Ahmad,Farhan Jalees
6) Iqbal, Zeenat
Jamia Hamdard, DELHI

Pharma academic research - Indian patent applications published on 9th January 2015

Dear All,
Every week of thousands of patent applications are published in India. The patent applications filed by the academic research institutes in India go un-noticed.
 
We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes.
 
For details of these patents, please write back to us at pharmaliterati@gmail.com
 
Indian patent applications published on 9th January 2015

Invention
Application No
Inventors
Institute
A pharmaceutical composition for mucoadhesive microparticles in the delivery of therapeutic agents
6636/CHE/2014 A
1) Dr. Anna Balaji
2) Ms. Swapna Sirikonda
Pathfinder institute of
Pharmacy education & Research. Opp Airport,
Besides Mamnoor Camp, Khammam Road,
Werangal, Karnataka
Novel fibrin nanoparticles useful for tissue engineering and drug delivery applications and a process for the preparation thereof
2010/DEL/2013 A
1) Sathyaraj Weslen Vedakumari
2) Thotapalli Parvathaleswara Sastry
Council of Scientific & Industrial
Research
 
 

National conference on Frontiers and avenues in the field of Herbal Drug Research

L M College Of Pharmacy is organizing two-days national conference on "Frontiers and avenues in the field of Herbal Drug Research."

The details are as follows:

Theme:             Frontiers and avenues in the field of Herbal Drug Research.

Dates:               6th and 7th February 2015.

Organized by:   Frontiers and avenues in the field of Herbal Drug Research. 

Location:           Ahmedabad.


Friday, 16 January 2015

Indian Patent Office rejects patent for Sofosbuvir.

Indian Patent Office has rejected a patent application for Sofosbuvir which was discovered by Pharmasset and developed by Gilead Sciences. Sofosbuvir is used against Hepatitis C. The patent application which was filed by Gilead covered the drug product which has been granted in several territories including US.

The price of patented medicines has always been a concern for the Indian healthcare industry. With this decision, we can be rest assured that patients with Hepatitis C would have access to affordable treatment options.

It is however worth noting that Indian companies like Cipla, Zydus, Hetero, Ranbaxy and others had entered into license agreements with Gilead to sell their product in India. Gilead had also planned to launch its own drug Sovaldi at the cost of 300USD per bottle. 

Wednesday, 7 January 2015

Innvoations in drug delivery: Trends, Opportunities and Regulatory Aspects

Vivekanand Education Society’s College Of Pharmacy is organizing one-day national seminar and poster competition on "Innovations in drug delivery: Trends, Opportunities and Regulatory Aspects."

The details are as follows:

Theme:             Innovations in drug delivery: Trends, Opportunities and Regulatory Aspects.

Dates:               24th January 2015.

Organized by:   Vivekanand Education Society’s College Of Pharmacy. 

Location:           Mumbai.



 
 
 
 


Various seminars at Sinhgad college of Pharmacy, Pune

Sinhgad Technical Education Society's Sinhgad college of Pharmacy is organizing Savitribai Phule Pune University sponsored 4 different seminars at Pune.

The details are as follows:

1. Theme: Lifecycle disorders: Avenues for Prophylaxis and Treatment

Dates: January 18 - 20, 2015.

2. Theme: Current strategies in targeting Tyrosine Kinase for Anticancer Research

Dates: January 21- 22, 2015.

3. Theme: The emerging threats of Dengue and Ebola Hemorrhagic Fever

Dates: January 28, 2015.

4. Theme: New insights into current pharmacovigilence

Dates: January 29, 2015.


Organized by: Sinhgad Technical Education Society's Sinhgad college of Pharmacy .

Location: Pune.

Details available at: http://www.sinhgad.edu/STES_Events_pdf_2015/SCOP/SCOP_Seminars_2015.pdf
 

Tuesday, 6 January 2015

7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014


Asia’s Biggest & Nation’s most awaited healthcare summit & Awards organized by healthcare communication leader Pharmaleaders, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014 held in Mumbai on 26th December 2014 at Hotel Sahara Star, Mumbai, India.

 The winners are as follows:

Category
Winner
Organization
India’s Most Admired Diabetologist 2014
Prof. (Dr) V.Mohan
CMD &  Chief Diabetologist, Dr. Mohan's Diabetes Specialties Centre
Healthcare Economist of the Year 2014
Dr Sanjeev Kanoria
Vice Chairman Austrian Anadi Bank AG & Chairman, Advinia Healthcare Ltd. 
Visionary Entrepreneur of the Year 2014
Mr. Dilip Surana
CMD, Microlabs Ltd. 
India’s Most Promising Orthopedic Surgeon
Dr. Chandrasekar Chikkamuniyappa
CEO  & Senior Joint Replacement Surgeon,  People Tree Hospitals
India's Most Promising Entrepreneur in Ayurvedic Beauty Care  of the year 2014
Dr.Ajayita Chanana
Founder & CEO, Dr. Ajayita's Charak Ayurvedic Clinic
Pharma Professional of the Decade
Mr. Daara Patel
Secretary General, Indian Drug Manufacturers Association
India’s Most Promising Healthcare Partner in Healthcare Innovations 2014
 
ConvaTec India Pvt Ltd. 
India’s Most Promising Nephrologist 2014
Prof. (Dr.) D. S. Rana
Chairman, Board of Management, Sir Ganga Ram Hospital
India’s Most Promising & Valuable Emerging Hospital of the Year 2014
 
People Tree Hospitals
India’s Most Promising Healthcare Innovator in Dermato-Cosmetic industry 2014
 
Adroit Biomed Ltd.
Healthcare Visionary of the Decade
Prof.(Dr.) B. Soma Raju,
Chief Cardiologist & CMD, Care Hospitals Group. 
India’s Most Promising & Valuable Diabetes-Cardiometabolic Clinic Chain 2014
 
Lifespan Clinic India
India’s Most technically & scientifically advanced Pharmaceutical Manufacturing Company of the year 2014
 
Akums Drugs & Pharmaceuticals Ltd
India’s Most Promising Pharmaceutical Logistics & Packaging Company 2014
 
Scorpion Group
India’s Most Promising Antiaging & Wellness Clinic 2014
 
AMAAYA™ Antiaging & Wellness Clinic. 
Transformational & Come Back Pharma Company of the year 2014
 
Dr Datsons Labs Ltd.
India’s Most Valuable Pharma Company in Exports & HR Excellence 2014
 
Galpha Laboratories Ltd.
India’s Most Promising Obesity Consultant 2014
Dr. Deepak V. Chaturvedi
Obesity & Anti-Aging Consultant, AMAAYA Antiaging & Wellness Clinic
India's Most Promising & Valuable Nutrition & Wellness  Company in Diet & Nutritional Counseling 2014
 
Anjali Mukerjee Health Total
Breakthrough Innovator in Cosmetic Dermatology 2014
Dr. Ruby Tandon
Cosmetic Dermatologist & Co-Founder, Dr Ruby’s After Glow Advanced Laser Clinic. 
India’s Most Valuable Revolutionary Pharma Company of the year 2014
 
Zuventus Healthcare Limited
Millennium Pharma Leader
Mr. Ajit Singh
Chairman, ACG Worldwide
India’s Most Admired Pharmaceutical Technocrat of the Decade
Dr. Ajit Dangi
President & CEO, Danssen Consulting
India’s Most Promising Business Leader of the Decade in  Hospital Management 2014
Dr. Sandeep Chatrath
C.E.O, Dharamshila Hospital And Research Centre
Excellence in Diet & Nutrition
Dr Shilpa Joshi
Consultant Dietician & Nutritionist